Uroplasty, Inc. UPI announced today that the United States Agency for Healthcare Research and Quality in a recently issued document titled "Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness" included favorable statements on the safety and effectiveness of percutaneous tibial nerve stimulation for overactive bladder.
Uroplasty's Urgent® PC Neuromodulation System is currently the only FDA-cleared product in the U.S. that delivers PTNS.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in